Global Healthcare Nanomedicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Healthcare Nanomedicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Healthcare nanomedicine refers to the application of nanotechnology in the field of medicine and healthcare. Nanotechnology involves manipulating materials at the nanoscale, typically at the level of atoms and molecules, to create structures and devices with unique properties and capabilities. When applied to healthcare, nanomedicine offers promising solutions for disease diagnosis, treatment, and prevention.
Healthcare Nanomedicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Healthcare Nanomedicine market is projected to reach US$ 392310 million in 2029, increasing from US$ 201240 million in 2022, with the CAGR of 10.0% during the period of 2024 to 2029. Demand from Anticancer and CNS Product are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Healthcare Nanomedicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Healthcare Nanomedicine key companies include Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen and Gilead Sciences, etc. Amgen, Teva Pharmaceuticals, UCB are top 3 players and held % share in total in 2022.
Healthcare Nanomedicine can be divided into Nanoparticle Drug and Nanocarrier Drug, etc. Nanoparticle Drug is the mainstream product in the market, accounting for % share globally in 2022.
Healthcare Nanomedicine is widely used in various fields, such as Anticancer, CNS Product, Anti-infective and Other, etc. Anticancer provides greatest supports to the Healthcare Nanomedicine industry development. In 2022, global % share of Healthcare Nanomedicine went into Anticancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Healthcare Nanomedicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Amgen
Teva Pharmaceuticals
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Gilead Sciences
Pfizer
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Segment by Type
Nanoparticle Drug
Nanocarrier Drug
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Healthcare Nanomedicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Healthcare Nanomedicine introduction, etc. Healthcare Nanomedicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Healthcare Nanomedicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Healthcare Nanomedicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Healthcare Nanomedicine market is projected to reach US$ 392310 million in 2029, increasing from US$ 201240 million in 2022, with the CAGR of 10.0% during the period of 2024 to 2029. Demand from Anticancer and CNS Product are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Healthcare Nanomedicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Healthcare Nanomedicine key companies include Amgen, Teva Pharmaceuticals, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen and Gilead Sciences, etc. Amgen, Teva Pharmaceuticals, UCB are top 3 players and held % share in total in 2022.
Healthcare Nanomedicine can be divided into Nanoparticle Drug and Nanocarrier Drug, etc. Nanoparticle Drug is the mainstream product in the market, accounting for % share globally in 2022.
Healthcare Nanomedicine is widely used in various fields, such as Anticancer, CNS Product, Anti-infective and Other, etc. Anticancer provides greatest supports to the Healthcare Nanomedicine industry development. In 2022, global % share of Healthcare Nanomedicine went into Anticancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Healthcare Nanomedicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Amgen
Teva Pharmaceuticals
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Gilead Sciences
Pfizer
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Segment by Type
Nanoparticle Drug
Nanocarrier Drug
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Healthcare Nanomedicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Healthcare Nanomedicine introduction, etc. Healthcare Nanomedicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Healthcare Nanomedicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices